Besides, EphA4 receptor is overexpressed in the EMT/stem‐like breast cancer cells (Lu et al., 2014) and Ephrin B2 is associated with progression and resistance to chemotherapy and radiation therapy in HNSCC (Oweida et al., 2017). The gene discussed is EFNB2; the disease is breast carcinoma.